Alexander D Cross - Net Worth and Insider Trading
Alexander D Cross Net Worth
The estimated net worth of Alexander D Cross is at least $356,774 dollars as of 2024-04-30. Alexander D Cross is the Director of Ligand Pharmaceuticals Inc and owns about 5,083 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $356,013. Alexander D Cross is also the Director of Atossa Therapeutics Inc and owns about 494 shares of Atossa Therapeutics Inc (ATOS) stock worth over $761. Details can be seen in Alexander D Cross's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Alexander D Cross has not made any transactions after 2013-05-15 and currently still holds the listed stock(s).
Transaction Summary of Alexander D Cross
Alexander D Cross Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alexander D Cross owns 3 companies in total, including Atossa Therapeutics Inc (ATOS) , Adhera Therapeutics Inc (ATRX) , and Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of Alexander D Cross’s form 4 insider trades.
Insider Ownership Summary of Alexander D Cross
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2013-05-15 | director |
| ATRX | Adhera Therapeutics Inc | 2005-07-20 | director |
| LGND | Ligand Pharmaceuticals Inc | 2006-09-27 | director |
Alexander D Cross Latest Holdings Summary
Alexander D Cross currently owns a total of 2 stocks. Among these stocks, Alexander D Cross owns 5,083 shares of Ligand Pharmaceuticals Inc (LGND) as of May 27, 2004, with a value of $356,013 and a weighting of 99.79%. Alexander D Cross also owns 494 shares of Atossa Therapeutics Inc (ATOS) as of May 15, 2013, with a value of $761 and a weighting of 0.21%.
Latest Holdings of Alexander D Cross
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2004-05-27 | 5,083 | 70.04 | 356,013 |
| ATOS | Atossa Therapeutics Inc | 2013-05-15 | 494 | 1.54 | 761 |
Holding Weightings of Alexander D Cross
Alexander D Cross Form 4 Trading Tracker
According to the SEC Form 4 filings, Alexander D Cross has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 333 shares on May 27, 2004, which brought Alexander D Cross around $42,000.
According to the SEC Form 4 filings, Alexander D Cross has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the acquisition of 3 shares on May 15, 2013, which cost Alexander D Cross around $2,745.
Insider Trading History of Alexander D Cross
- 1
Alexander D Cross Trading Performance
GuruFocus tracks the stock performance after each of Alexander D Cross's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alexander D Cross is -16.7%. GuruFocus also compares Alexander D Cross's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alexander D Cross within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alexander D Cross's insider trading performs compared to the benchmark.
Performance of Alexander D Cross
Average Return
-77.98%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.19 | -16.7 | -61.1 | -77.98 | -46.84 | -63.58 |
| Relative Return to S&P 500(%) | -9.26 | -16.85 | -69.5 | -90.76 | -59.96 | -70.84 |
Alexander D Cross Ownership Network
Ownership Network List of Alexander D Cross
Ownership Network Relation of Alexander D Cross
Alexander D Cross Owned Company Details
What does Atossa Therapeutics Inc do?
Who are the key executives at Atossa Therapeutics Inc?
Alexander D Cross is the director of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .
Atossa Therapeutics Inc (ATOS) Insider Trades Summary
Over the past 18 months, Alexander D Cross made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .
In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 25,000 shares, with a net purchase of 25,000 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atossa Therapeutics Inc Insider Transactions
Alexander D Cross Mailing Address
Above is the net worth, insider trading, and ownership report for Alexander D Cross. You might contact Alexander D Cross via mailing address: C/o Ligand Pharmaceuticals Inc.,, 10275 Science Center Dr., San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
